CSL-360 is a chimeric non-conjugated IgG1 monoclonal antibody that targets CD123. It effectively inhibits the binding of IL-3 to CD123, thereby preventing IL-3-induced cell proliferation. CSL-360 is utilized in research related to acute myeloid leukemia (AML).
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
